Medpace Holdings, Inc.
MEDP
Classement en actions
#1306
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a... Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
Prix de l'action
$622.03
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$17.36B
Changement (1 jour)
0.38%
Changement (1 an)
14.00%
Pays
US
Échange Medpace Holdings, Inc. (MEDP)
Catégorie
Healthcare
Ratio P/B pour Medpace Holdings, Inc. (MEDP)
Ratio P/B au October 2026 TTM : 40.23
Selon les derniers rapports financiers et le cours de l'action de Medpace Holdings, Inc., le ratio cours/valeur comptable actuel (TTM) est 40.23. À la fin de 2024, le ratio P/B était de 12.46.
Historique du ratio P/B pour Medpace Holdings, Inc. de 2013 à 2026
Ratio P/B à la fin de chaque année
| Année | Ratio P/B | Changez |
|---|---|---|
| 2026 (TTM) | 40.23 | 14.01% |
| 2025 | 35.29 | 183.28% |
| 2024 | 12.46 | -26.06% |
| 2023 | 16.85 | -5.37% |
| 2022 | 17.80 | 117.38% |
| 2021 | 8.19 | 33.05% |
| 2020 | 6.16 | 48.23% |
| 2019 | 4.15 | 30.16% |
| 2018 | 3.19 | 13.44% |
| 2017 | 2.81 | 33.43% |
| 2016 | 2.11 | -20.86% |
| 2015 | 2.66 | 30.90% |
| 2014 | 2.03 | 0.00% |
| 2013 | 0.00 | 0.00% |
Ratio P/B pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/B | Différence de Ratio P/B | Pays |
|---|---|---|---|
| 4.7411 | -88.22% |
US
|
|
| 3.0143 | -92.51% |
US
|
|
| 31.051 | -22.82% |
US
|
|
| - | - |
CN
|
|
| 6.6641 | -83.44% |
US
|
